doi:10.1016/0304-3835(83)90114-3.[Crossref], [PubMed], [Web of Science ] , [Google Scholar]
The mechanism of action includes several key effects: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood sugar levels Suppressing glucagon release , thereby reducing glucose production by the liver Slowing gastric emptying , which prolongs the feeling of fullness after meals Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger and food intake Most GLP-1 medications are administered via subcutaneous injection , either once weekly (semaglutide, dulaglutide) or once daily (liraglutide), depending on the specific formulation
23 Animal studies have demonstrated neuroprotective effects associated with GLP-1RA use in Alzheimer and Parkinson disease, stroke, and ocular hypertension
In midlife care, the sequence of intervention often determines the sustainability of results
The success rate of the cool cap can vary from person to person
This reduces hunger, supports calorie reduction, and leads to improved glycemic control
